Patent · US Active

Thienopyridine inhibitors of RIPK2

US11168093B2 · kind B2 · utility

0Cited by
15References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2019
Grant dateNov 9, 2021
Priority date
Expiry dateDec 29, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.